In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
Dermatologist examining skin on the face of older man.
In the Clinic
Immunotherapy Drug Shows Promise for Metastatic Merkel Cell Carcinoma

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.
Memorial Sloan Kettering surgeon Daniela Molena
In the Clinic
When Is Heartburn a Sign of Esophageal Cancer?

Many people don’t know that gastroesophageal reflux disease (GERD) is a potentially serious condition that — if left untreated — can ultimately lead to esophageal cancer.
Male scientist wearing protective gear working with radiopharmaceutical materials.
Article
Theranostics: A Powerful Diagnostic Tool and Cancer Treatment in One

Thanks to pioneering work done at MSK, a powerful new form of radiation therapy is changing the treatment of advanced cancers.
Pictured: Eric Holland, Franziska Michor, and Desert Horse-Grant
New Center Uses Mathematical Models to Understand Cancer

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.
Scientists at the Sloan Kettering Institute are learning why some immune cells are stubbornly hard to revive with immunotherapy.
In the Lab
Why Immune Cells Sometimes Fail to Fight Cancer (and What to Do about It)

By looking at how DNA is packaged in cells, scientists are teasing apart a long-standing conundrum about the immune response to cancer.
A young man sitting in a restaurant with a slice of cake in front of him
No Longer Left Behind in Cancer Clinical Trials

Nearly every advance in cancer care today is possible because of clinical trials. MSK is breaking down the age barrier that has made it hard for young patients such as Irving Romero Torres to participate in and benefit from clinical research.
Francis M. Sirotnak
FDA Approves Lymphoma Drug Developed at Memorial Sloan Kettering

Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.
Dennis Flaherty
Feature
How MSK Is Helping Dennis Survive Stage 4 Kidney Cancer

When Dennis Flaherty was diagnosed with stage 4 kidney cancer, he knew he wanted to be treated at MSK. His story illustrates why U.S. News & World Report ranked MSK the top hospital in the country for urology care in 2023.
Pictured: David Solit
Profile
At Work: Physician-Scientist David Solit

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.
Four dogs wearing blue bandanas are held on leashes in a hallway at Memorial Hospital. Three handlers are seen only from the waist down.
Feature
Top Dogs: Meet MSK’s Four-Legged Volunteers

The Caring Canines program at Memorial Sloan Kettering has been going strong for more than 12 years.